Legal Representation
Attorney
Erica Halstead
USPTO Deadlines
Next Deadline
1071 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20221129)
Due Date
November 29, 2028
Grace Period Ends
May 29, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 12, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Mar 21, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Mar 21, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Feb 28, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Nov 29, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 29, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 3, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Sep 13, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 13, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 7, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Sep 7, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Aug 24, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 8, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 5, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 5, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 5, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 21, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 2, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 2, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 3, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 4, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 21, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jul 27, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of microangiopathies, diabetic retinopathy, symptoms of chronic venous insufficiency in the lower limbs, namely pain, cramps, paraesthesia, oedema, and stasis dermatosis, superficial thrombophlebitis, post-thrombotic syndrome, microcirculatory disorders of arteriovenous origin and hemorrhoidal syndrome, hemorrhoidal syndrome, hemorrhoidectomy, capillary hemorrhages caused by menorrhagia, metrorrhagia, vascularised tissues, epistaxis and periventricular hemorrhage in newborns, recurrent respiratory tract infections, asthma, recurrent wheezing, atopic dermatitis, recurrent and chronic urinary tract infections, and acute urinary tract infections; sanitary preparations for medical purposes; medical plasters; food for babies; materials for dental fillings and dental impressions; disinfectants
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical devices to administer pharmaceutical preparations, namely inhalers; artificial limbs, eyes and teeth; suture materials
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical and veterinary services; hygienic and beauty care services for human beings or animals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized wording "OM PHARMA" with a drop design breaking through the top center of the letter "O".
Classification
International Classes
005
010
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"